It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).

Skip Navigation

A commitment to investors

As we prepare for the next phase of our journey, we are committed to working on your behalf to build long-term shareholder value in pursuit of our mission.

Our performance


Baxter delivered on a wide range of strategic objectives in 2014: We launched innovative healthcare technologies, advanced our new product development pipeline and expanded the global reach of our core portfolio. Our actions reflect Baxter's ongoing commitment to accelerating value for patients, investors, employees, and other stakeholders in line with our mission to save and sustain lives.

View our latest Annual Report
0.19 (0.53%)
Baxter International Inc.
NYSE: BAXFeb 09, 2016 - 4:01 PM ET
Stock chart for: BAX.  Currently trading at $36.19 with a 52 week high of $43.44 and a 52 week low of $32.18.
Data provided by Nasdaq. Minimum 15 minutes delayed.
See stock & dividend information
Financial Information

Access financial schedules and filings

Shareholder Information

Read the latest FAQs

Spin-Off Information

Find more on the recent spin-off

Investor Conference

View replay and supporting materials

Investor relations contact

Analysts, portfolio managers, and current and prospective shareholders seeking additional investor information can contact Clare Trachtman at +1 (224) 948-3085.

Retail shareholder inquires may directed to Baxter Investor Relations at Global_CORP_Investor_Relations@baxter.com.

Sign up for email alerts